Expression of the serum response factor in hepatocellular carcinoma: Implications for epithelial-mesenchymal transition

International Journal of Oncology

Volumn 31, Issue 6, 2007, Pages 1309-1315

  Park, Min Young ^a   Kim, Kyung Ryoul ^a   Park, Ho Sung ^a   Park, Byung Hyun ^a   Choi, Ha Na ^a   Jang, Kyu Yun ^a   Chung, Myoung Ja ^a   Kang, Myoung Jae ^a   Lee, Dong Geun ^a   Moon, Woo Sung ^a  

^a Chonbuk National University   (South Korea)

Author keywords

Epithelial mesenchymal transition; Hepatocellular carcinoma; Serum response factor; Vimentin

Indexed keywords

SERUM RESPONSE FACTOR; VIMENTIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INVASION; CELL TRANSFORMATION; CHEMISTRY; EPITHELIUM; FEMALE; HUMAN; IMMEDIATE EARLY GENE; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MESODERM; METABOLISM; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; TUMOR CELL LINE;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIUM; FEMALE; GENES, IMMEDIATE-EARLY; HUMANS; LIVER NEOPLASMS; MALE; MESODERM; MIDDLE AGED; NEOPLASM INVASIVENESS; RETROSPECTIVE STUDIES; SERUM RESPONSE FACTOR; VIMENTIN;

EID: 38449102928     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.31.6.1309     Document Type: Article

References (35)

1. Boyer B, Valles AM and Edme N: Induction and regulation of epithelial-mesenchymal transitions. Biochem Pharmacol 60: 1091-1099, 2000.
2. Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454, 2002.
3. Hay ED and Zuk A: Transformations between epithelium and mesenchyme: normal, pathological and experimentally induced. Am J Kidney Dis 26: 678-690, 1995.
4. Hu L, Lau SH, Tzang CH, Wen JM, Wang W, Xie D, Huang M, Wang Y, Wu MC, Huang JF, Zeng WF, Sham JS, Yang M and Guan XY: Association of vimentin overexpression and hepatocellular carcinoma metastasis. Oncogene 23: 298-302, 2004.
5. Hendrix MJ, Seftor EA, Seftor RE and Trevor KT: Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior. Am J Pathol 150: 483-495, 1997.
6. Gilles C, Polette M, Piette J, Delvigne AC, Thompson EW, Foidart JM and Birembaut P: Vimentin expression in cervical carcinomas: association with invasive and migratory potential. J Pathol 180: 175-180, 1996.
7. Lang SH, Hyde C, Reid IN, Hitchcock IS, Hart CA, Bryden AA, Villette JM, Stower MJ and Maitland NJ: Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma. Prostate 52: 253-263, 2002.
8. Treisman R: Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors. Cell 46: 567-574, 1986.
9. Shore P and Sharrocks AD: The MADS-box family of transcription factors. Eur J Biochem 229: 1-13, 1995.
10. Norman C, Runswick M, Pollock R and Treisman R: Isolation and properties of cDNA clones encoding SRF, a transcription factor that binds to the c-fos serum response element. Cell 55: 989-1003, 1998.
11. Sobue K, Hayashi K and Nishida W: Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation. Mol Cell Biochem 190: 105-118, 1999.
12. Chai J and Tarnawski AS: Serum response factor: discovery, biochemistry, biological roles and implications for tissue injury healing. J Physiol Pharmacol 53: 147-157, 2002. (Pubitemid 34717237)
13. Schratt G, Weinhold B, Lundberg AS, Schuck S, Berger J, Schwarz H, Weinberg RA, Ruther U and Nordheim A: Serum response factor is required for immediate-early gene activation yet is dispensable for proliferation of embryonic stem cells. Mol Cell Biol 21: 2933-2943, 2001.
14. Camoretti-Mercado B, Liu HW, Halayko AJ, Forsythe SM, Kyle JW, Li B, Fu Y, McConville J, Kogut P, Vieira JE, Patel NM, Hershenson MB, Fuchs E, Sinha S, Miano JM, Parmacek MS, Burkhardt JK and Solway J: Physiological control of smooth muscle-specific gene expression through regulated nuclear translocation of serum response factor. J Biol Chem 275: 30387-30393, 2000.
15. Ding W, Gao S and Scott RE: Senescence represses the nuclear localization of the serum response factor and differentiation regulates its nuclear localization with lineage specificity. J Cell Sci 114: 1011-1018, 2001.
16. Bertolotto C, Ricci JE, Luciano F, Mari B, Chambard JC and Auberger P: Cleavage of the serum response factor during death receptor-induced apoptosis results in an inhibition of the c-FOS promoter transcriptional activity. J Biol Chem 275: 12941-12947, 2000.
17. Zhang X, Chai J, Azhar G, Sheridan P, Borras AM, Furr MC, Khrapko K, Lawitts J, Misra RP and Wei JY: Early postnatal cardiac changes and premature death in transgenic mice overexpressing a mutant form of serum response factor. J Biol Chem 276: 40033-40040, 2001. (Pubitemid 37391419)
18. Yamaguchi H, Wyckoff J and Condeelis J: Cell migration in tumors. Curr Opin Cell Biol 17: 559-564, 2005.
19. Hood JD and Cheresh DA: Role of integrins in cell invasion and migration. Nat Rev Cancer 2: 91-100, 2002.
20. Bashyam MD: Understanding cancer metastasis: an urgent need for using differential gene expression analysis. Cancer 94: 1821-1829, 2002.
21. Psichari E, Balmain A, Plows D, Zoumpourlis V and Pintzas A: High activity of serum response factor in the mesenchymal transition of epithelial tumor cells is regulated by RhoA signaling. J Biol Chem 277: 29490-29495, 2002.
22. Kim DG, Park SY, Kim H, Chun YH, Moon WS and Park SH: A comprehensive karyotypic analysis on a newly established sarcomatoid hepatocellular carcinoma cell line SH-J1 by comparative genomic hybridization and chromosome painting. Cancer Genet Cytogenet 132: 120-124, 2002.
23. Moon WS, Tarnawski AS, Chai J, Yang JT and Majumdar AP: Reduced expression of epidermal growth factor receptor related protein in gastric cancer. Gut 54: 201-206, 2005.
24. Pai R, Nakamura T, Moon WS and Tarnawski AS: Prostaglandins promote colon cancer cell invasion; signaling by cross-talk between two distinct growth factor receptors. FASEB J 17: 1640-1647, 2003. (Pubitemid 37100065)
25. DeVita VT, Hellman S and Rosenberg SA: Cancer: Principles and Practice of Oncology. 6th edition. Lippincott-Raven, New York, 2001.
26. Thompson EW and Newgreen DF: Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res 65: 5991-5995, 2005.
27. Kakizoe S, Kojiro M and Nakashima T: Hepatocellular carcinoma with sarcomatous change. Clinicopathologic and immunohistochemical studies of 14 autopsy cases. Cancer 59: 310-316, 1987.
28. Nishi H, Taguchi K, Asayama Y, Aishima S, Sugimachi K, Nawata H and Tsuneyoshi M: Sarcomatous hepatocellular carcinoma: a special reference to ordinary hepatocellular carcinoma. J Gastroenterol Hepatol 18: 415-423, 2003.
29. Watanabe J, Nakashima O and Kojiro M: Clinicopathologic study on lymph node metastasis of hepatocellular carcinoma: a retrospective study of 660 consecutive autopsy cases. Jpn J Clin Oncol 24: 37-41, 1994.
30. Muller R, Bravo R, Burckhardt J and Curran T: Induction of c-fos gene and protein by growth factors precedes activation of c-myc. Nature 312: 716-720, 1985.
31. Mejlvang J, Kriajevska M, Berditchevski F, Bronstein I, Lukanidin EM, Pringle JH, Mellon JK and Tulchinsky EM: Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition. Exp Cell Res 313: 380-393, 2007.
32. Hendrix MJ, Seftor EA, Chu YW, Trevor KT and Seftor RE: Role of intermediate filaments in migration, invasion and metastasis. Cancer Metastasis Rev 15: 507-525, 1996.
33. Osada T, Sakamoto M, Ino Y, Iwamatsu A, Matsuno Y, Muto T and Hirohashi S: E-cadherin is involved in the intrahepatic metastasis of hepatocellular carcinoma. Hepatology 24: 1460-1467, 1996. (Pubitemid 26399050)
34. Takeichi M: Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251: 1451-1455, 1991. (Pubitemid 121000430)
35. Hirohashi S and Kanai Y: Cell adhesion system and human cancer morphogenesis. Cancer Sci 94: 575-581, 2003. (Pubitemid 36975010)